11/03/2026
π lt is World Glaucoma Week. Often referred to as 'the sneak thief of eyesight', glaucoma can go undetected in many people without regular eye testing, as the most common form of it has no symptoms. Read on here, about some new research which is being conducted by Centre for Eye Research, Australia, for supplementary co-management approaches to possibly add to required ongoing traditional medical control.
It's World Glaucoma Week, and weβre highlighting the important work of Dr Flora Hui, whose research is helping uncover new ways to prevent vision loss caused by glaucoma.
Dr Hui co-leads worldβfirst international clinical trials with Professor Pete Williams exploring how nicotinamide β a form of vitamin B3 β may help power the cells in the eye and support current treatments like eye drops and surgery.
βWe have known for a long time now that eye pressure is not the final story in glaucoma,β says Dr Hui.
People can develop glaucoma even when their eye pressure isnβt high. And even when pressure is lowered, up to a third of people still continue to progress towards blindness.
Earlier work at CERA suggested that insufficient energy supply to the retina may be a key factor in glaucoma, showing that mitochondria β the energy source for nerve cells β donβt work as they should.
This research led to CERAβs first clinical trial into vitamin B3 supplementation, which produced positive results. Independent studies overseas have since supported these findings, and a longer international trial is now underway across Australia, Singapore, Sweden and the United Kingdom.
Your support today helps accelerate breakthroughs in our clinical trials and drive the next generation of treatments.
Donate today to support our groundbreaking research (link in comments) π